These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1815588)

  • 1. Characterization of the immunochemical reactivity of fibrinogen fragments by competitive radioimmunoassay: an improved method of analysis.
    Winzor DJ; Nagy JA; Scheraga HA
    J Protein Chem; 1991 Dec; 10(6):629-35. PubMed ID: 1815588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational equilibria in the gamma chain COOH terminus of human fibrinogen.
    Cierniewski CS; Budzynski AZ
    J Biol Chem; 1987 Oct; 262(29):13896-901. PubMed ID: 3654644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation of the Müller method to allow quantitative characterization of the affinity and cross-reactivity of antibodies by competitive radioimmunoassay.
    Winzor DJ; Bowles MR; Pentel PR; Schoof DD; Pond SM
    Mol Immunol; 1991 Sep; 28(9):995-1001. PubMed ID: 1922113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteroides gingivalis and Bacteroides intermedius recognize different sites on human fibrinogen.
    Lantz MS; Allen RD; Bounelis P; Switalski LM; Hook M
    J Bacteriol; 1990 Feb; 172(2):716-26. PubMed ID: 2404954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical determination of conformational equilibria for fragments of the B beta chain of fibrinogen.
    Nagy JA; Meinwald YC; Scheraga HA
    Biochemistry; 1985 Feb; 24(4):882-7. PubMed ID: 2581607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical studies on human fibrinogen and its fragments. Cross-reactivity of NH2-terminal "Disulfide Knot" and related structures as determined by radioimmunoassay.
    Kudryk B; Reuterby J; Blombäck B
    Eur J Biochem; 1974 Jul; 46(1):141-7. PubMed ID: 4136797
    [No Abstract]   [Full Text] [Related]  

  • 7. Conformation of the carboxy-terminal region of the A alpha chain of fibrinogen as elucidated by immunochemical analyses.
    Cierniewski CS; Plow EF; Edgington TS
    Eur J Biochem; 1984 Jun; 141(3):489-96. PubMed ID: 6204869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hybrid peptide analogs to receptor recognition domains on alpha- and gamma-chains of human fibrinogen on fibrinogen binding to platelets.
    Mohri H; Ohkubo T
    Thromb Haemost; 1993 May; 69(5):490-5. PubMed ID: 8322271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q component of complement binds to fibrinogen and fibrin.
    Entwistle RA; Furcht LT
    Biochemistry; 1988 Jan; 27(1):507-12. PubMed ID: 3258162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution NMR studies of fibrinogen-like peptides in solution: structure of a thrombin-bound peptide corresponding to residues 7-16 of the A alpha chain of human fibrinogen.
    Ni F; Meinwald YC; Vásquez M; Scheraga HA
    Biochemistry; 1989 Apr; 28(7):3094-105. PubMed ID: 2742827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.
    Peerschke EI; Galanakis DK
    J Lab Clin Med; 1983 Mar; 101(3):453-60. PubMed ID: 6827176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet receptor recognition domain on the gamma chain of human fibrinogen and its synthetic peptide analogues.
    Kloczewiak M; Timmons S; Bednarek MA; Sakon M; Hawiger J
    Biochemistry; 1989 Apr; 28(7):2915-9. PubMed ID: 2742819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen binds to integrin alpha(5)beta(1) via the carboxyl-terminal RGD site of the Aalpha-chain.
    Suehiro K; Mizuguchi J; Nishiyama K; Iwanaga S; Farrell DH; Ohtaki S
    J Biochem; 2000 Oct; 128(4):705-10. PubMed ID: 11011154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo.
    Plow E; Edgington TS
    J Clin Invest; 1973 Feb; 52(2):273-82. PubMed ID: 4119160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of fibrinogen and fibrinopeptide A containing fibrinogen fragments with antisera to fibrinopeptide A.
    Canfield RE; Dean J; Nossel HL; Butler VP; Wilner GD
    Biochemistry; 1976 Mar; 15(6):1203-9. PubMed ID: 943180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further probes into quantitative aspects of competitive binding assays: allowance for effects of antigen multivalency in immunoassays.
    Hogg PJ; Winzor DJ
    Arch Biochem Biophys; 1987 Apr; 254(1):92-101. PubMed ID: 3579309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of results from the competitive Biacore procedure for characterizing immunochemical interactions in solution.
    Winzor DJ
    J Mol Recognit; 2018 Jul; 31(7):e2702. PubMed ID: 29484741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical determination of conformational equilibria for fragments of the A alpha chain of fibrinogen.
    Nagy JA; Meinwald YC; Scheraga HA
    Biochemistry; 1982 Apr; 21(8):1794-806. PubMed ID: 7082648
    [No Abstract]   [Full Text] [Related]  

  • 19. Affinity purification of an acylated and radiolabelled synthetic derivative of residues 75-83 of bovine myelin basic protein, [125I]S79. A model for the purification of picomole quantities of specific peptide fragments of myelin basic protein and antibodies against them.
    Day ED; Hashim GA; Varitek VA; Lazarus KJ; Paterson PY
    J Neuroimmunol; 1981 Sep; 1(3):311-24. PubMed ID: 6174544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminating neoantigenic differences between fibrinogen and fibrin derivatives.
    Plow EF; Edgington TS
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1169-73. PubMed ID: 4123931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.